Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-049221

Chief Accounting Officer & VP gave up 1,520 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monohon Ted Chief Accounting Officer & VP 2022-09-06 Shares withheld for taxes −1,520 $1.64 $2,493 30,951 D: show line 1 in the form
Loading xslF345X03/doc4.xml…